| PAHO - PBE website

SP 2026-2031

3.2

OUTCOME

Communicable diseases, antimicrobial resistance, and immunization

Accelerate the disease elimination agenda and better prevent and treat communicable diseases, noncommunicable diseases, and mental health conditions

High

Scope

Scope: This outcome aims to improve the health system’s response capacity to prevent, control, and eliminate communicable diseases, including vaccine-preventable diseases, by ensuring access to interventions throughout the life course and addressing the needs of vulnerable populations. Achieving this outcome will require strengthening response capacity at the first level of care, as well as close intersectoral coordination to address the social and environmental determinants of health and reduce health disparities in collaboration with civil society. Specifically, the following actions will be implemented:

Strengthen country capacity to ensure access for all to comprehensive, person-centered health services by leveraging evidence-based strategies, primary health care, life-course approaches, and robust governance and financing to effectively prevent, control, and eliminate communicable diseases and sustain elimination gains.
Advance coordinated efforts to ensure access for all to essential health technologies, such as diagnostics, vaccines, vector control measures, and treatments, and accelerate the adoption and use of innovative solutions to effectively and sustainably prevent, control, and eliminate communicable diseases and related conditions and protect elimination gains.
Improve information, surveillance, public health laboratory systems and networks, and the capacity to integrate human, animal health, and environmental efforts to anticipate risks, prioritize resources, and ensure effective responses for the prevention, control, and elimination of diseases, outbreaks, and antimicrobial resistance.
Intensify efforts to control and eliminate communicable diseases and related conditions and safeguard elimination gains, through the incorporation of an approach that recognizes the interconnectedness of human, animal, and environmental health.
Facilitate effective and comprehensive participation processes that empower civil society and communities to actively and meaningfully engage in planning, implementing, monitoring, and evaluating integrated strategies and health services to prevent, control, and eliminate communicable diseases and related conditions, while protecting elimination gains. This includes the development of communications strategies to increase public trust and customize messages to specific contexts and populations about vaccines and other countermeasures.

Outcome indicators

SP20–25

4.a

SHAA 2030

10.1

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	71%
Target Year:	2031	Target Value:	95%

SP20–25

4.c

SHAA 2030

10.3

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	16
Target Year:	2031	Target Value:	37

SP20–25

Modifies 4.d

SHAA 2030

10.2

GPW

N/A

SDG

N/A

Baseline Year:	2022	Baseline Value:	72%
Target Year:	2031	Target Value:	90%

SP20–25

Modifies 4.e

SHAA 2030

10.6

GPW

N/A

SDG

N/A

Baseline Year:	2023	Baseline Value:	7
Target Year:	2031	Target Value:	16

SP20–25

4.f

SHAA 2030

10.10

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	10
Target Year:	2031	Target Value:	15

SP20–25

Modifies 17.c

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	0
Target Year:	2031	Target Value:	4

SP20–25

Modifies 17.c

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	0
Target Year:	2031	Target Value:	23

SP20–25

Modifies 17.c

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	0
Target Year:	2031	Target Value:	13

SP20–25

Modifies 17.c

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	2
Target Year:	2031	Target Value:	3

SP20–25

Modifies 17.c

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	2
Target Year:	2031	Target Value:	2

SP20–25

Modifies 17.c

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	1
Target Year:	2031	Target Value:	37

SP20–25

Modifies 12.b

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	3
Target Year:	2031	Target Value:	21

SP20–25

New

SHAA 2030

10.7

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	1
Target Year:	2031	Target Value:	18

SP20–25

12.d

SHAA 2030

10.9

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	15
Target Year:	2031	Target Value:	26

SP20–25

Modifies 4.h

SHAA 2030

5.2

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	3
Target Year:	2031	Target Value:	38

SP20–25

Modifies 4.j

SHAA 2030

10.4

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	6
Target Year:	2031	Target Value:	27

SP20–25

Modifies 17.e

SHAA 2030

10.4

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	0
Target Year:	2031	Target Value:	0

SP20–25

Modifies 17.g

SHAA 2030

10.4

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	0
Target Year:	2031	Target Value:	0

SP20–25

Modifies 12.c

SHAA 2030

10.8

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	4
Target Year:	2031	Target Value:	28

SP20–25

New

SHAA 2030

N/A

GPW

N/A

SDG

N/A

Baseline Year:	2025	Baseline Value:	6
Target Year:	2031	Target Value:	35

Resolution CD61.R6 – Strategy and Plan of Action to Decrease the Burden of Sepsis through an Integrated
Approach 2025–2029 (Document CD61/5) (2024)

UN Political Declaration on antimicrobial resistance (2024)

Resolution CSP30.R13 – Keeping the Region of the Americas Free of Polio (Document CSP30/19, Rev. 1) (2022)

Resolution CD59.R4 – One Health: A Comprehensive Approach for Addressing Health Threats at the
Human-Animal-Environment Interface (Document CD59/9) (2021)

Resolution CD59.R13 – Reinvigorating Immunization as a Public Good for Universal Health (Document CD59/10)
(2021)

Resolution WHA74.9 – Recommitting to accelerate progress towards malaria elimination (2021)

Resolution WHA 73.5 – Strengthening efforts on food safety (2020)

Resolution CD57.R7 – PAHO Disease Elimination Initiative: A Policy for an Integrated Sustainable Approach to
Communicable Diseases in the Americas (Document CD57/7) (2019)

Resolution CD56.R2 – Plan of Action on Entomology and Vector Control 2018-2023 (Document CD56/11) (2018)

Resolution WHA71.5 – Addressing the burden of snakebite envenoming (2018)

UN Political Declaration on Tuberculosis (2018)

Resolution CSP29.R11 – Plan of Action for the Sustainability of Measles, Rubella, and Congenital Rubella Syndrome
Elimination in the Americas 2018-2023 (Document CSP29/8) (2017)

Resolution CD55.R6 – Strategy for Arboviral Disease Prevention and Control (Document CD55/16) (2016)

Resolution CD55.R7 – Plan of Action for Malaria Elimination 2016–2020 (Document CD55/13) (2016)

Resolution WHA68.2 – Global technical strategy and targets for malaria 2016–2030 (2015)

Resolution CD52.R14 – Evidence-based Policy-making for National Immunization Programs (Document CD52/9)
(2013)

Resolution CSP27.R15 – Dengue Prevention and Control in the Americas (2007)

Resolution CD44.R9 – Dengue (2003)

High

3.2.1 Antiretroviral treatment (ART) coverage among people living with HIV

3.2.2 Number of countries and territories with at least 95% coverage of syphilis treatment in pregnant women

3.2.3 Tuberculosis treatment success rate

3.2.4 Number of countries and territories with reduced malaria test positivity rate

3.2.5 Number of countries and territories that conduct integrated, collaborative surveillance of arbovirus cases

3.2.6 (a) Number of endemic countries and territories that have eliminated one or more Neglected Tropical Diseases (NTDs), based on the applicable PAHO/WHO elimination protocols: Trachoma

3.2.6 (b) Number of endemic countries and territories that have eliminated one or more Neglected Tropical Diseases (NTDs), based on the applicable PAHO/WHO elimination protocols: Yaws

3.2.6 (c) Number of endemic countries and territories that have eliminated one or more Neglected Tropical Diseases (NTDs), based on the applicable PAHO/WHO elimination protocols: Leprosy

3.2.6 (d) Number of endemic countries and territories that have eliminated one or more Neglected Tropical Diseases (NTDs), based on the applicable PAHO/WHO elimination protocols: Lymphatic filariasis

3.2.6 (e) Number of endemic countries and territories that have eliminated one or more Neglected Tropical Diseases (NTDs), based on the applicable PAHO/WHO elimination protocols: Onchocerciasis

3.2.6 (f) Number of endemic countries and territories that have eliminated one or more Neglected Tropical Diseases (NTDs), based on the applicable PAHO/WHO elimination protocols: Human Rabies transmitted by dogs

3.2.7 Number of countries and territories that have interrupted vector-borne transmission of Chagas disease, in all or in part of their endemic areas, for all species of triatomine vectors present

3.2.8 Number of endemic countries in which at least 90% of newly detected cutaneous leishmaniasis cases are treated

3.2.9 Number of countries and territories that have adequate mechanisms in place to prevent or mitigate risks to food safety

3.2.10 Number of countries and territories reporting at least 95% coverage of 3 doses of diphtheria, pertussis, and tetanus-containing vaccine (DPT3) in 80% of municipalities in children less than one year of age

3.2.11 Number of countries and territories that achieved at least 90% of one dose of HPV vaccine coverage in girls by age 15

3.2.12 Number of countries and territories in which endemic transmission of measles or rubella has been reestablished

3.2.13 Number of countries and territories with no polio virus circulation in the event of an importation of wild poliovirus (WPV), circulating vaccine-derived poliovirus (cVDPV), or the emergence of a VDPV

3.2.14 Number of countries and territories that test for resistance among all bacterial and fungal GLASS pathogens and have effective treatment available for the resistant pathogens detected

3.2.15 Number of countries and territories implementing intersectoral One Health policies, programs, and activities at the human-animal-environment interface